Researchers from VCU Massey Cancer Center, the University of Florida College of Medicine, and UF Health Cancer Center found that minority patient participation in cancer clinical trials is low—in part due to standard clinical trial criteria that disproportionately exclude Black patients.
Researchers at the University of California San Diego and La Jolla Institute of Immunology have discovered a promising treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The approach leverages the body’s natural immune response to cytomegalovirus, a common but typically harmless virus that most people are infected with at some point in their lives.
